Glucose Monitoring Device Market: Market Size & Forecast 2026

Glucose monitoring devices help individuals with diabetes track their blood sugar levels to manage their condition effectively. The market is broadly divided into self-monitoring blood glucose devices, which use finger-prick testing, and continuous glucose monitoring systems that provide real-time readings through subcutaneous sensors. Revenues of roughly $17.2 billion in 2025 reflect sustained demand, with projections extending toward $39.8 billion by 2035 as technology improves and patient adoption deepens.

• •Comprises blood glucose meters, test strips, lancets, and continuous glucose monitoring sensors and transmitters
• •Serves both Type 1 and Type 2 diabetes patients, as well as those with gestational diabetes
• •Markets research suggests continued expansion through the 2030s with sustained double-digit potential in certain segments

The International Diabetes Federation estimates over 500 million adults living with diabetes globally, creating a large and expanding patient base. Rising healthcare spending, improved diagnosis rates, and growing awareness of glucose management benefits are fueling demand. Advances in sensor accuracy, longer wear times, and integration with smartphones and insulin pumps have made continuous monitoring more appealing to patients and clinicians.

• •Favorable reimbursement policies in North America and Europe are accelerating CGM adoption over traditional testing methods
• •Obesity rates and sedentary lifestyles are contributing to climbing Type 2 diabetes incidence across all regions
• •Telehealth expansion and remote patient monitoring have increased the appeal of connected glucose monitoring devices

By product type, the market is split between self-monitoring blood glucose devices and continuous glucose monitoring systems, with CGM gaining share due to better patient outcomes and convenience. Geographically, North America leads in revenue due to high diabetes prevalence and strong insurance coverage, while the Asia-Pacific region is expected to grow fastest as disposable income rises and healthcare infrastructure improves.

• •North America accounts for the largest market share, followed by Europe and then Asia-Pacific
• •Hospitals, clinics, and home care settings are the primary end users, with home use growing rapidly
• •Major growth opportunities exist in emerging markets including China, India, Brazil, and Southeast Asian nations

What are the recent trends and outlook?

The industry is seeing a clear shift from reactive self-testing to proactive continuous monitoring, with CGM penetration expected to keep rising. Newer devices offer longer sensor life, better accuracy, and seamless connectivity to mobile apps and electronic health records. Future growth will likely be supported by efforts to make CGM affordable without insurance, expand into non-diabetic wellness applications such as metabolic health monitoring, and incorporate artificial intelligence for predictive glucose alerts.

• •Over-the-counter CGM availability for non-diabetic consumers is emerging as a new market segment
• •Multi hormone sensing and integration with closed-loop insulin delivery systems represent the next innovation frontier
• •Competition is expected to intensify, potentially lowering prices and broadening access in price-sensitive regions